Canopy Growth Corporation (CGC)

Market Cap	895.76M
Revenue (ttm)	321.87M
Net Income (ttm)	-2.29B
Shares Out	494.89M
EPS (ttm)	-5.43
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,311,060
Open	1.81
Previous Close	1.81
Day's Range	1.80 - 1.86
52-Week Range	1.80 - 8.64
Beta	2.28
Analysts	Sell
Price Target	2.43 (+34.25%)
Earnings Date	Feb 9, 2023

About CGC

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Fr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Mr. David Eric Klein
• Employees: 3,151
• Stock Exchange: NASDAQ
• Ticker Symbol: CGC

Financial Performance

In 2022, Canopy Growth's revenue was 520.33 million, a decrease of -4.82% compared to the previous year's 546.65 million. Losses were -302.18 million, -82.68% less than in 2021.

Financial numbers in CAD

Analyst Forecast

According to 23 analysts, the average rating for CGC stock is "Sell." The 12-month stock price forecast is $2.43, which is an increase of 34.25% from the latest price.

Price Target

$2.43

(34.25% upside)

Analyst Consensus: Sell